Curriculum Vitae. CV Chairman ITERA Life-Sciences Forum: Personal data:
|
|
|
- Elaine Smith
- 10 years ago
- Views:
Transcription
1 CV Chairman ITERA Life-Sciences Forum: Curriculum Vitae Personal data: Name: Ramon First name: Albert Nationality: Belgian Place/ date of birth: Torhout, Belgium Address: Stationsstraat 56/9, B-3620 Lanaken Education: - Doctor in medical and biomedical Sciences. - Euro Doctor certificate in Immunology (Auto Immune Diseases and Immunology) - Master in Business Administration (MBA), Strategic Marketing - Boerhaeve Certificate Infections Diseases Job experience ( Functions) Institution 1: Function: Institution 2: Function: University Hospital of Antwerp, Belgium Department of Gastroenterohepatology (Immunology and Infections diseases) Consultant Institute of Genetics, Molecular biology, Cologne, Germany Investigator Research Projects
2 References: 2010 Awarded with the Otto Meyerhof Price in Neuss, Germany Otto Meyerhof (Nobel Price 1922) 2011 As President of ITERA, received the UNESCO recognition of the International Code of Ethics, presented by the UNESCO Chair of BioEthics and Human Rights Prof Dr Alberto Garcia Gomez (21 November 2011) 2011 Invited by the The University of Queensland Australia to participate on the Comparative Study of Processses, Systems and Regulations in Manufacturing and Application of Stem Cells and other Cell Therapies Invited speaker at the 4th Annual Congress of Industrial Biotechnology 2011 China Dalian 2010 Invited Guest lector at the Theodor Bilhartz Institute Cairo-Egypt 2010 Member of different Scientific Societies BASL, IPLASS, GSZ, ISHD 2010 Elected as member of the Advisory Board of Directors Unithink (DOMO-group) 2010 Invited as ITERA Chairman at the World Congress TERMIS in Vienna 2012 (Tissue Engineering and Regenerative Medicine Society) Consultant of Immunologic and Infectious Diseases, at the University Hospital of Antwerp, dept. Gastroenterohepatology headed by Prof. Dr. P. Pelckmans, and Prof. Dr. P. Michielsen 2009 Nanotechnology in Medicine, R&D Project in cooperation with WFUBMC, ITERM, Vision4 Life-Sciences, and ECMTA Guest lector at the Baptist Wake Forest University, Institute for Tissue Engineering and Regenerative Medicine 2009 Founding member of ITERM ( Institute of Tissue Engineering and Regenerative Medicine) at Lukas Hospital Neuss, Germany 2009 CMO Unithink (Chief Medical Officer) 2008 Organizer of the 4 th Symposium ITERA The theme of this year s workshop is Stem Cells: From the basic research to the pre-clinical and clinical applications Invited speaker on the C.E. Alken-Preisträger Mannheim Study Project: Optimization and application of a nanotechnology based amplification technique for visualizing various biomolecules. Prof. Marc Ramael, Prof. Dr. A. Ramon
3 2007 Organizer of the 3 rd Symposium ITERA, Theme 3 rd symposium: Stem Cells from the cord-blood, cord and placenta; scientific approaches, pre-clinical and clinical applications Founder and CEO Vision4 Life-Sciences, Think tank for Innovative Applications in Pharma- and Biotech Industries Co-investigator for 8 Projects submitted for the EU Frame Works, 3 projects awarded. ITERA members participated in HEPADIB HYPERLAB 2006 Organizer of the 2 nd ITERAsymposium, Research Project Hepatic Cells, Isolation, differentiation, characterization and functional properties. Project leader A. Ramon 2005 Organizer of the 1 st ITERA symposium Result ITERA workshops, EU project CRYSTAL, Cryo-banking of Stem Cells for Human Therapeutic AppLication or CRYSTAL. Leading Prof. Dr. Hesschler, (Univ. Cologne in 5 EU Universities and one SME Cryo-Save. European s largest Private Family Stem Cell Bank) 2004 Co-Founder of ECMTA (European Centre of Medical and Technical Applications), Director Dr. A. Jung and Mss. Dr. Jung Paul Schalluckstrasse 8, Köln 2004 Founder und Initiator European Centre of Imaging and Biometry ECIMB Leuven, Belgium Training Centre for diagnostic Radiology 2004 Founder, Initiator and Chairman ITERA (International Tissue Engineering Research Association) 2004 Invited guest lector Stem Cell Institute Minneapolis, Minnesota, U.S.A (December 2004) 2004 Co-Investigator in COOP : Project New Vaccination Therapies for Lung Cancer Research & Development of the RIDIS system 2003 (Real Intelligent Data Informatics System) Product Cooperation with ZeitControl Minden and Unithink, A Platform for individual clinical data AIMO Coordinator and partner in Design and Optimization of an RNA-modified Dendritic Cell Vaccine for Cancer. Univ. Hospital Antwerp, UZA
4 2002 Co-author. Molecular diagnosis and Lab-on-a-Strip Founder und Chairman AIMO Organiser of different Workshops in Maastricht (AIMO = Autologous ImmunoModulated Onco-Vaccination therapy group) 2000 Scientific advisor EUREGIO Biotechnology Park, University Maastricht, Drs. René Vleugels 1999 Investigator and Research Collaboration Fibrosis Marker with Bayer AG Leverkussen Germany 1999 Co-Author Handbook Immunopathology of Liver Diseases: An Overview Diagnostic and Clinical Aspects. Authors: Prof. Dr. Krueger GRF, A. Ramon AMC 1999 Guest editor InterVirology, International Journal Novel Immunology Aspects of CMV-Related Diseases. Pathogenesis, Diagnosis, and Therapy 1998 Elected member of the International Scientific Professionals (Who s WHO) 1998 Co-organizer and speaker at the International Workshop on HSV infections, Kerkrade, Netherlands headed by Prof. Dr. Krueger GRF Co-author Study Protocol on Cytokines in Obesity, Are circulating cytokines playing a role in obesity. A CYTOB-pilot study. headed by Prof. Dr. Van Gaal, University Hospital, Antwerp Dept. Endocrinology Co investigator in a Benelux Hepatitis C study Protocol Consultant Dept of Microbiology at the University of Maastricht. Investigator CMV patent CMV Patent, Co-author: Human Cytomegalovirus Antigen and its use (Triple Antigen) n Chairman and speaker ELAS meeting Brussels Cytokines and Liver diseases, New Biomarkers. Hypothesis as novel Biomarkers in Liver dieases. (European Ligand Assay Society) 1994 Genzyme, Virotech Award, Award for the Contribution in R&D and QCM of different projects
5 1992 Organon Teknika Award (AKZO Nobel Award 1992): Partner in Research and Development 1990 Co-author of Clinical Study of Psychoneuro-Immunological and Endocrine Network Regulation of Growth and Metastasis in Human Breast Cancer Patients. Project Officer: Prof. Dr. GRF Krueger 1989 Invited guest-lector at the University of Houston Medical School Invited guest lector : Lyme Project at the Gustav Liebig University, Prof. Dr. Wellensiek 1989 Co-founder International Institute of Immunopathology, Köln, (USA, Japan, Mexico) Director Prof. Dr. GRF Krueger Co-investigator in an EU Frame Work Project n DE07PUJU1 Pathogenesis of Malignant Lymphomas Epidemiology Immunopathology and Virology studies in prelymphomatous conditions (incl. AIDS) and in malignant lymphomas. Director Prof. Dr. GRF Krueger Co-investigator in a Clinical Trial, International IVIG Study protocol in ARC (Aids Related Complex) Prof. Dr. Krueger GRF, (visiting Fellow Prof. Dr. Gallo)
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine
Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:
FACULTY OF ALLIED HEALTH SCIENCES
FACULTY OF ALLIED HEALTH SCIENCES 102 Naresuan University FACULTY OF ALLIED HEALTH SCIENCES has focused on providing strong professional programs, including Medical established as one of the leading institutes
FACULTY OF MEDICAL SCIENCE
Doctor of Philosophy Program in Microbiology FACULTY OF MEDICAL SCIENCE Naresuan University 171 Doctor of Philosophy Program in Microbiology The time is critical now for graduate education and research
CURRICULUM VITAE. 1231 Conches (Swtzerland) 0041-76-316.10.38 (personal assistant) Private phone number 0041-22-830.15.45
1Curriculum vitae F.A. Waldvogel, M.D. 1 CURRICULUM VITAE WALDVOGEL Francis A. Origin Geneva (Switzerland) Date of birth October 19, 1938 Languages French, German, English (fluent) Italian (good understanding)
Personalized medicine in China s healthcare system
Personalized medicine in China s healthcare system Jingmin Kan, Sam Linsen Netherlands office for Science and Technology, Guangzhou and Shanghai, China Content PERSONALIZED MEDICINE 2 FOCUS AT THE INDIVIDUAL
THE LINCOLN INSTITUTE OF HEALTH
THE LINCOLN INSTITUTE OF HEALTH Background The Chair in the Care of the Older Person will be part of the new Lincoln Institute of Health, a cross disciplinary research collaboration linking schools, colleges
Join our scientific talent community
Join our scientific talent community There has never been a better time to be a part of Janssen Research & Development. We are at the forefront of healthcare leading, evolving and transforming it into
Increasing Innovation in R&D - Seizing early stage external growth opportunities
Increasing Innovation in R&D - Seizing early stage external growth opportunities Paul R. Eynott, PhD sanofi-aventis, US [email protected] -1- Sommaire -2- CHRISTOPHER A. VIEHBACHER Chief Executive
To be taught at the Ausia Biotech Aseptic Training Center in Hangzhou China
Come learn from our 3-day course! Introduction to Aseptic Processing To be taught at the Ausia Biotech Aseptic Training Center in Hangzhou China March 23-25, 2016 1. Introduction to TPA-IT: China s only
E UROPEAN PERSONAL INFORMATION
E UROPEAN CURRICULUM VITAE FORMAT PERSONAL INFORMATION Name Work Address ARTURO CHITI Humanitas University, Via A. Manzoni 113, 20089 Rozzano (MI), Italy Nuclear Medicine Department, Humanitas Research
AREAS OF CONCENTRATION
CANCER EPIDEMIOLOGY Dr. Elizabeth Platz, Director The mission of the Cancer Area of Concentration is to train future epidemiologists armed with the knowledge and skills to investigate: The causes of cancer,
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT
GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT 1) TOPIC OF THE EVENT MALIGNANT PLEURAL DISEASE 2) SUGGESTED TITLE : Approach to Pleural Cancer: State-of-the-Art 3) TYPE OF EVENT Course Native
Ph.D. in Molecular Medicine
Ph.D. in Molecular Medicine and Translational Research College of Medicine 1. Introduction: The College of Medicine, while consolidating on its undergraduate innovative educational programs, decided to
Roche Position on Human Stem Cells
Roche Position on Human Stem Cells Background Stem cells and treating diseases. Stem cells and their applications offer an enormous potential for the treatment and even the cure of diseases, along with
7- Doctoral Degree in Public Health and Public Health Sciences (Majoring Microbiology)
7- Doctoral Degree in Public Health and Public Health Sciences (Majoring Microbiology) Students should fulfill a total of 44 credit hours: 1- Compulsory courses: 14 credit hours. 1504801, 1504802, 1504803,
Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 [email protected]
Sarah A. Haecker, PhD 1782 Humboldt Avenue Minneapolis, Minnesota 55403 612.202.6805 [email protected] PROFILE Successful Senior Executive, skilled in Corporate Development including Business
TRACKS GENETIC EPIDEMIOLOGY
Dr. Priya Duggal, Director In the post-genomic era where larger amounts of genetic data are now readily available, it has become increasingly important to design studies and use analytical techniques that
SACKLER SCHOOL OF GRADUATE BIOMEDICAL SCIENCES CATALOG 2015-2016 PROGRAMS OF STUDY, COURSES AND REQUIREMENTS FOR ALL GRADUATE PROGRAMS
SACKLER SCHOOL OF GRADUATE BIOMEDICAL SCIENCES CATALOG 2015-2016 PROGRAMS OF STUDY, COURSES AND REQUIREMENTS FOR ALL GRADUATE PROGRAMS Graduate Programs CELL, MOLECULAR, AND DEVELOPMENTAL BIOLOGY CLINICAL
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE
GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE Personal Information Date of birth July 2, 1953 Place of birth Torino, Italy Office address Department of Oncology S. Luigi Gonzaga Hospital, Oncology
Stemlife tomorrow s lifeline
StemlifeTM Frequently Asked Questions 1300 553 474 www.stemlife.com.au TM Stemlife 1. COLLECTION OF CORD STEM CELLS Does Stemlife collect Cord Tissue? Absolutely. In fact, Stemlife provides the most advanced
TERUMO Corporation Business Strategy Conference
TERUMO Corporation Business Strategy Conference THERAPEUTIC SYSTEMS & CELL PROCESSING MARK FLOWER GLOBAL MARKETING December 5, 2011 Regenerative Medicine, Cell Therapy, & Cell Processing Regenerative Medicine
BACHELOR OF SCIENCE IN MICROBIOLOGY
BACHELOR OF SCIENCE IN MICROBIOLOGY The goal of the B.S. Microbiology program at Albany College of Pharmacy and Health Sciences is to prepare graduates for employment or advanced study in fields requiring
Molecular Biotechnology Master s Degree Program
> APPLIED LIFE SCIENCES Master s Degree Program: > FULL TIME Molecular Biotechnology Master s Degree Program www.fh-campuswien.ac.at My Occupational Future. Your Career Opportunities Biotechnology is one
HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE. Field. Translational Research. Mortality Analysis. Public Health.
HEALTH SCIENCES RESEARCH GROUPS AT THE UNIVERSITY OF ALICANTE Field Name Description Translational Research Mortality Analysis Join University-Conselleria Unit for Translational Research in the health
CAREERS IN BIOMEDICAL SCIENCE & THE IBMS. Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire
CAREERS IN BIOMEDICAL SCIENCE & THE IBMS Betty Kyle Scottish Regional Representative IBMS Lead Biomedical Scientist NHS Lanarkshire What is a biomedical scientist? Biomedical scientists carry out investigations
Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology
Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology The Master Degree in Medical Laboratory Sciences / Clinical Microbiology, Immunology or
LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO. @LSQld
LIFE SCIENCES QUEENSLAND LIMITED (LSQ) Mario Pennisi CEO @LSQld LEADING DESTINATION FOR CLINICAL RESEARCH INVESTORS IN QLD INCLUDE: LIFE SCIENCES IN QLD ~300 companies in life sciences ~$5B invested by
MOLOGEN AG German Equity Forum 2015
German Equity Forum 2015 Dr. Mariola Söhngen Chief Executive Officer Frankfurt am Main 24 November 2015 We are Pioneers in the Field of Immunotherapies Biotechnology company with focus on immunotherapies
Future Oncology: Technology, Products, Market and Service Opportunities
Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter
Nuevas tecnologías basadas en biomarcadores para oncología
Nuevas tecnologías basadas en biomarcadores para oncología Simposio ASEBIO 14 de marzo 2013, PCB Jose Jimeno, MD, PhD Co-Founder / Vice Chairman Pangaea Biotech SL Barcelona, Spain PANGAEA BIOTECH BUSINESS
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong. Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015
Ethics and Scientific Oversight for Phase 1 Clinical Trials in Hong Kong Sydney TANG Chairman, HKU/HA HKW IRB November 21, 2015 Clinical Trials at HKU Phase 1 Phase II Phase III Phase IV Conducted on patient
New York Bio Conference 2016. Mark J. Alles Chief Executive Officer
New York Bio Conference 2016 Mark J. Alles Chief Executive Officer Great Progress AGE 72 World Life Expectancy 2005-2014* 17 new drugs for rare diseases 71.5 71 Two new MS drugs First drug to target root
TRACKS INFECTIOUS DISEASE EPIDEMIOLOGY
Dr. Shruti Mehta, Director The development of antibiotics, improved access to safe food, clean water, sewage disposal and vaccines has led to dramatic progress in controlling infectious diseases. Despite
Editorial. Yves Levy, Executive Director
Editorial Yves Levy, Executive Director I am delighted to announce the creation of a new research centre: the Vaccine Research Institute (VRI). The VRI addresses the unprecedented challenge of developing
Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020
Il ruolo dell Advisory Group for «Health, Wellbeing and Demographic Change» in Horizon 2020 Lucia Monaco Horizon 2020 Advisory Group, Societal Challenges 1: Health, Demographic Change and Wellbeing Seminario:
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1
1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY
Clinical trials: The EU perspective. Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission
Clinical trials: The EU perspective Dr Karim Berkouk, Deputy Head of Unit DG for Research and Innovation Health Directorate European Commission Content 1.EU: The global picture 2.EU & Clinial trials: The
ITT Advanced Medical Technologies - A Programmer's Overview
ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) ITT Advanced Medical Technologies (Ileri Tip Teknolojileri) is a biotechnology company (SME) established in Turkey. Its activity area is research,
Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare
Exploratory Brief on Nanomedicine or the Application of Nanotechnology in Human Healthcare Paula Corabian, Dagmara Chojecki March 6, 2012 Objectives Provincial Health Technology Assessment (HTA) Program
Course Descriptions. I. Professional Courses: MSEG 7216: Introduction to Infectious Diseases (Medical Students)
Course Descriptions I. Professional Courses: MSEG 7216: Introduction to Infectious Diseases (Medical Students) This course is offered during the first semester of the second year of the MD Program. It
Amel Abd Allah Hashim Ahmed
Amel Abd Allah Hashim Ahmed Lecturer of Biochemistry & Molecular Biology PERSONAL PROFILE Nationality: Egyptian Work: Faculty of Pharmacy, Helwan University, Ain-Helwan, Helwan, Egypt. Work phone: 25590000-
MOLOGEN AG. Q1 Results 2015 Conference Call Dr. Matthias Schroff Chief Executive Officer. Berlin, 12 May 2015
Q1 Results 2015 Conference Call Dr. Matthias Schroff Chief Executive Officer Berlin, 12 May 2015 V1-6 Disclaimer Certain statements in this presentation contain formulations or terms referring to the future
Biomedical Engineering Medical Faculty Mannheim, Heidelberg University
International Master of Science in Biomedical Engineering Joint Degree University of and Shanghai Jiao Tong University The contents of the program cover all aspects of the innovative field of computational
Medical Laboratory Technology Program. Student Learning Outcomes & Course Descriptions with Learning Objectives
Medical Laboratory Technology Program Student Learning Outcomes & Course Descriptions with Learning Objectives Medical Laboratory Technology Student Learning Outcomes All Colorado Mesa University associate
Doctoral Program Department of Microbiology and Immunology
Doctoral Program Department of Microbiology and Immunology (05/12/2011 revised) Graduate studies in the Department of Microbiology and Immunology are designed to provide the doctoral student with a broad
Bachelor of Science in Applied Bioengineering
Bachelor of Science in Applied Bioengineering Applied bioengineering employs scientific and engineering principles to process biological materials from biological agents for provision of goods and related
1. Program Title Master of Science Program in Biochemistry (International Program)
1 Program Structure and Specification Master of Science Program in Biochemistry (International Program) Curriculum Last Revised in 2012 for Students Entering in Academic Year 2016 -----------------------------------------
The National Centre for Biomedical Engineering Science
The How this Integrated Technology Platform has impacted the development of R&D Clusters in Galway Jacinta Thornton, PhD Executive Manager, NCBES National Centre for Biomedical Engineering g Science Mission
Sepax. your child s cord blood is in safe hands. World leader in adult stem cell processing
Sepax your child s cord blood is in safe hands World leader in adult stem cell processing Biosafe Experience Credibility Innovation Dear Customer, Innovation in cell processing is our credo and this is
Master s of Science (M.S.) in Infectious Disease and Immunology
Master s of Science (M.S.) in Infectious Disease and Immunology A unique two-year, full-time translational research-intensive program that leads to an advanced career in health-related fields. INTRODUCING
Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning Outcomes
Department/Academic Unit: Pathology and Molecular Medicine Degree Program: PhD Degree Level Expectations, Learning Outcomes, Indicators of Achievement and the Program Requirements that Support the Learning
7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology)
7- Master s Degree in Public Health and Public Health Sciences (Majoring Microbiology) Students should fulfill a total of 38 credit hours: 1- Basic requirements: 10 credit hours. 150701, 150702, 150703,
Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO
Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO Statistically significant difference in progression-free survival continues to be seen in non-squamous
Educational Opportunities at Temple University. Deborah B. Nelson, Ph.D. [email protected] January 21, 2012
Educational Opportunities at Temple University Deborah B. Nelson, Ph.D. [email protected] January 21, 2012 Educational Opportunities at Temple University Master of Science in Clinical Research and Translational
Organ on Chip. Developing tools for new, better and personalized therapies. Organ on Chip
Organ on Chip Developing tools for new, better and personalized therapies Organ on Chip Organs on Chip for tailor-made medicine Professor Albert van den Berg received his PhD at the University of Twente
Technology funding opportunities at the National Cancer Institute
Technology funding opportunities at the National Cancer Institute Through the Cancer Diagnosis Program http://cancerdiagnosis.nci.nih.gov/index.html Avraham Rasooly Ph.D. National Cancer Institute, Cancer
CURRICULUM VITAE. Igor V. Maslov. 1-24-17-6 Sasazuka, Shibuya-ku Phone: +81 (80) 54863304. Web: http://www.columbia.edu/~ivm3/
CURRICULUM VITAE 1 Igor V. Maslov Contact information 1-24-17-6 Sasazuka, Shibuya-ku Phone: +81 (80) 54863304 Tokyo 151-0073 E-mail: [email protected] Japan Web: http://www.columbia.edu/~ivm3/ Education
The Commercialization of Technology Concepts into Medical Products
The Commercialization of Technology Concepts into Medical Products Kevin J. Scanlon, Ph.D. New Zealand 2006 International BioScience Overview Pharmaceutical Industry Biotechnology Startups Investment Community
Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry
Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Biochemistry The Master Degree in Medical Laboratory Sciences /Clinical Biochemistry, is awarded by the Faculty of Graduate Studies
The Academy of Clinical Science and Laboratory Medicine Pathways to Fellowship
The Academy of Clinical Science and Laboratory Medicine Revision 1 February 2015. Contents: 1 Introduction... 2 2 Constitution... 2 3 Qualification... 2 3.1 Accredited Masters Programmes... 3 3.2 Approved
Appendices Master s degree programme Biomedical Engineering 2011-2012
Appendices Master s degree programme Biomedical Engineering 2011-2012 Appendix A Learning outcomes of the degree programme (art. 1.3) The graduate in Biomedical Engineering (BME): 1. has basic knowledge
15350 Sherman Way, Suite 350 Van Nuys, CA 91406 Phone 877-310-0717 Fax 818-251-5300 www.hemacare.com. April 17, 2015.
15350 Sherman Way, Suite 350 Van Nuys, CA 91406 Phone 877-310-0717 Fax 818-251-5300 www.hemacare.com April 17, 2015 Dear Shareholder, We are experiencing exciting times at HemaCare. Over the course of
Biostatistics Credit 15 5 10 1. Integrated and Interdisciplinary Training 2/7 Credit 24 24 1
1st Year Hours SEMESTER I Exam or credit Total Lecture Seminar Classes ECTS Anatomy 1/2* Credit 100 20 80 9 Biophysics Exam 55 15 10 30 4 First Aid in Emergency Situations Credit 20 6 4 10 1 Histology
Clinical Research Infrastructure
Clinical Research Infrastructure Enhancing UK s Clinical Research Capabilities & Technologies At least 150m to establish /develop cutting-edge technological infrastructure, UK wide. to bring into practice
Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health
1 Biostatistics Statistical Methods & Theory Evidence-Based Practice for Public Health Identified Knowledge Domains of Public Health General Public Health Epidemiology Risk Assessment Population-Based
Groundbreaking Collaborative Clinical Trial Launched
Groundbreaking Collaborative Clinical Trial Launched For immediate release Media Contacts: June 16, 2014 Richard Folkers Alison Hendrie 9:00 a.m., EDT Foundation for the NIH Rubenstein Communications (301)
This is GE Healthcare
This is GE Healthcare An Overview Imagination at work Last updated July 2014 General Electric: A heritage of innovation Founded by Thomas Edison in 1878 Only company from the original 1896 Dow Jones index
BIOLOGICAL SCIENCES REQUIREMENTS [63 75 UNITS]
Biological Sciences Major The Biological Sciences address many of the most important and fundamental questions about our world: What is life? How does our brain produce our ideas and emotions? What are
Sponsoring concept. International MD/PhD Program Molecular Medicine. Hannover Medical School, Germany. Content. I. Mission and Aims 2
Sponsoring concept International MD/PhD Program Molecular Medicine Hannover Medical School, Germany Content I. Mission and Aims 2 1. Mission 2 2. Global Aims 2 3. Strategic Aims 2 II. Sponsoring concept
Janssen Research & Development 3210 Merryfield Row San Diego, CA 92121
NHLBI SAN DIEGO INNOVATION CONFERENCE JUNE 11, 2013 Janssen Research & Development 3210 Merryfield Row San Diego, CA 92121 Agenda Speaker Bios 10:30-11:00 a.m. Registration 11:00-11:15 a.m. Welcome Remarks
Bio Deutschland CEO & CFO-Meeting 29. November 2012. Unternehmertum in den Life Sciences am Beispiel der Geschichte von Miltenyi Biotec
Bio Deutschland CEO & CFO-Meeting 29. November 2012 Unternehmertum in den Life Sciences am Beispiel der Geschichte von Miltenyi Biotec Major locations Köln Our Passion SHARING OUR PASSION FOR CELLS We
PROJECT GROUP FOR AUTOMATION IN MEDICINE AND BIOTECHNOLOGY IN MANNHEIM BIOPROCESS ENGINEERING
Fraunhofer Institute for Manufacturing Engineering and Automation IPA PROJECT GROUP FOR AUTOMATION IN MEDICINE AND BIOTECHNOLOGY IN MANNHEIM BIOPROCESS ENGINEERING VERGÜTUNG VON ERFINDUNGEN UND TECHNISCHEN
Biochemistry Major Talk 2014-15. Welcome!!!!!!!!!!!!!!
Biochemistry Major Talk 2014-15 August 14, 2015 Department of Biochemistry The University of Hong Kong Welcome!!!!!!!!!!!!!! Introduction to Biochemistry A four-minute video: http://www.youtube.com/watch?v=tpbamzq_pue&l
NP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
The Evolution of Graduate Education in the College of Medicine. Office of Graduate & Postdoctoral Affairs School of Basic Biomedical Sciences
The Evolution of Graduate Education in the College of Medicine Office of Graduate & Postdoctoral Affairs Graduate Education in the College of Medicine Graduate Programs in Integrated Graduate Education
Hong Kong Poised to be the Asia s Biotechnology Hub
Think Asia, think Hong Kong - London 13-09-2011 www.hkbio.org.hk BioTech at Science Park Your Safe and Fast Track to China Hong Kong Poised to be the Asia s Biotechnology Hub Albert Cheung Hoi Yu, Ph.D.
School of Public Health and Health Services Department of Epidemiology and Biostatistics
School of Public Health and Health Services Department of Epidemiology and Biostatistics Graduate Certificate Public Health Microbiology and Emerging Infectious Diseases 2011-2012 Program Directors for
FOR TEXTILES. o Kuchipudi-I] textiles. Outdoor Activity Based Courses. Camp
SEMESTER I Basic Sciences Courses o General Chemistry o Biology for Engineers o Fundamentals of Mathematics o Applied Physics-I for Life Science Behavioural Science o Understanding Self for Effectiveness
www.terrapinn.com/cordblood Top 10 global cord blood banks
Top 10 global cord blood banks The top 10 global cord blood banks Which cord blood banks around the world are the most influential and innovative? This is the question we asked ourselves as we began research
Innovation Platform: Sudden Cardiac Death
Innovation Platform: Sudden Cardiac Death Prof. dr. Bart Loeys CRC Antwerp General Assembly VzW Board of Directors Strategic Advisory Board Staff: 1 executive director 1 ICT manager 1 financial administration
Curriculum Vitae SILVIA PREITE
Curriculum Vitae SILVIA PREITE PERSONAL DATA Current position:, Via Vincenzo Vela 6, 6500, Bellinzona (Switzerland) Cell phone: +41 767861119 or +39 3490541497 Email address: [email protected],
How To Learn More About Melanoma
PROGRAMMA SCIENTIFICO MELANOMA BRIDGE 2012, DECEMBER 2 ND -4 TH 2012 Presidents: Paolo A. Ascierto, Francesco M. Marincola and Nicola Mozzillo Scientific Board Paolo A. Ascierto Gennaro Ciliberto Bernard
Professional Science Masters Degrees. What are PSM degrees?
Professional Science Masters Degrees Charles E. Schmidt College of Science Presentation to FAU Board of Trustees April 21, 2010 by Dean Gary W. Perry What are PSM degrees? Professional Science Master programs
Master of Science in Molecular Biology
Master of Science in Molecular Biology Molecular Biology Molecular biology is the discipline within the life sciences aimed at understanding the molecular basis of life in health and disease. It is a multidisciplinary
Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing
Fit for Health 2.0 - International Strategy Development Training Innovative Business Solutions and Smart Financing Thursday 08 October 2015 8-9 October 2015, Copenhagen (Denmark) Medicon Valley Alliance,
CV - Curriculum Vitae
Bengt Arne Sjöqvist Born: August 8, 1952 Family: Engaged, 2 children born 1988 and 1991 Adress: Tärneskärsgatan 28, 421 57 Västra Frölunda, Sweden Tel. +46 31-709 86 26 (private) +46 70-787 77 97 (mobile)
Anforderungen der Life-Science Industrie an die Hochschulen. Hans Widmer Novartis Institutes for BioMedical Research
Anforderungen der Life-Science Industrie an die Hochschulen Hans Widmer Novartis Institutes for BioMedical Research There s nothing more extraordinary than a normal life 2 What does industry expect from
Human stem cell research: a novel technology that will benefit patients Information and Position Paper
October 2003 Human stem cell research: a novel technology that will benefit patients Information and Position Paper EuropaBio, the European Association for Bio-industries, has 35 corporate members operating
